Acknowledgement
This work was funded by grants from the National Natural Science Foundation of China (81602108, 71974153) and the Provincial College Students' Innovative Entrepreneurial Training Program in Hubei (201810488115).
References
- Balachandran, V.P., Beatty, G.L., and Dougan, S.K. (2019). Broadening the impact of immunotherapy to pancreatic cancer: challenges and opportunities. Gastroenterology 156, 2056-2072. https://doi.org/10.1053/j.gastro.2018.12.038
- Bazzichetto, C., Conciatori, F., Luchini, C., Simionato, F., Santoro, R., Vaccaro, V., Corbo, V., Falcone, I., Ferretti, G., Cognetti, F., et al. (2020). From genetic alterations to tumor microenvironment: the Ariadne's string in pancreatic cancer. Cells 9, 309. https://doi.org/10.3390/cells9020309
- Chen, G., Le, Y., Zhou, L., Gong, L., Li, X., Li, Y., Liao, Q., Duan, K., Tong, J., and Ouyang, W. (2016). Dexmedetomidine inhibits maturation and function of human cord blood-derived dendritic cells by interfering with synthesis and secretion of IL-12 and IL-23. PLoS One 11, e0153288. https://doi.org/10.1371/journal.pone.0153288
- Chen, I.L., Todd, I., Tighe, P.J., and Fairclough, L.C. (2020). Electronic cigarette vapour moderately stimulates pro-inflammatory signalling pathways and interleukin-6 production by human monocyte-derived dendritic cells. Arch. Toxicol. 94, 2097-2112. https://doi.org/10.1007/s00204-020-02757-8
- Chyuan, I.T. and Lai, J.H. (2020). New insights into the IL-12 and IL-23: from a molecular basis to clinical application in immune-mediated inflammation and cancers. Biochem. Pharmacol. 175, 113928. https://doi.org/10.1016/j.bcp.2020.113928
- Conejo-Garcia, J.R., Rutkowski, M.R., and Cubillos-Ruiz, J.R. (2016). State-of-the-art of regulatory dendritic cells in cancer. Pharmacol. Ther. 164, 97-104. https://doi.org/10.1016/j.pharmthera.2016.04.003
- Deicher, A., Andersson, R., Tingstedt, B., Lindell, G., Bauden, M., and Ansari, D. (2018). Targeting dendritic cells in pancreatic ductal adenocarcinoma. Cancer Cell Int. 18, 85. https://doi.org/10.1186/s12935-018-0585-0
- Dudek, A.M., Martin, S., Garg, A.D., and Agostinis, P. (2013). Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front. Immunol. 4, 438. https://doi.org/10.3389/fimmu.2013.00438
- Foley, K., Kim, V., Jaffee, E., and Zheng, L. (2016). Current progress in immunotherapy for pancreatic cancer. Cancer Lett. 381, 244-251. https://doi.org/10.1016/j.canlet.2015.12.020
- Fukunaga, A., Miyamoto, M., Cho, Y., Murakami, S., Kawarada, Y., Oshikiri, T., Kato, K., Kurokawa, T., Suzuoki, M., Nakakubo, Y., et al. (2004). Cd8+ tumor-infiltrating lymphocytes together with Cd4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28, e26-e31. https://doi.org/10.1097/00006676-200401000-00023
- Gabrilovich, D. (2004). Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4, 941-952. https://doi.org/10.1038/nri1498
- Giovanelli, P., Sandoval, T.A., and Cubillos-Ruiz, J.R. (2019). Dendritic cell metabolism and function in tumors. Trends Immunol. 40, 699-718. https://doi.org/10.1016/j.it.2019.06.004
- He, S., Fei, M., Wu, Y., Zheng, D., Wan, D., Wang, L., and Li, D. (2011). Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients. Int. J. Mol. Sci. 12, 7424-7437. https://doi.org/10.3390/ijms12117424
- Hegde, S., Krisnawan, V.E., Herzog, B.H., Zuo, C., Breden, M.A., Knolhoff, B.L., Hogg, G.D., Tang, J.P., Baer, J.M., Mpoy, C., et al. (2020). Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer. Cancer Cell 37, 289-307.e9. https://doi.org/10.1016/j.ccell.2020.02.008
- Hirooka, S., Yanagimoto, H., Satoi, S., Yamamoto, T., Toyokawa, H., Yamaki, S., Yui, R., Inoue, K., Michiura, T., and Kwon, A.H. (2011). The role of circulating dendritic cells in patients with unresectable pancreatic cancer. Anticancer Res. 31, 3827-3834.
- Liu, X., Wang, J., Wang, H., Yin, G., Liu, Y., Lei, X., and Xiang, M. (2015). REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: involvement of a REG3A-JAK2/STAT3 positive feedback loop. Cancer Lett. 362, 45-60. https://doi.org/10.1016/j.canlet.2015.03.014
- Liu, X., Zhou, Z., Cheng, Q., Wang, H., Cao, H., Xu, Q., Tuo, Y., Jiang, L., Zou, Y., Ren, H., et al. (2017). Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression. Cell Death Dis. 8, e3033. https://doi.org/10.1038/cddis.2017.424
- Ma, C., Su, M., Shen, K., Chen, J., Ning, Y., and Qi, C. (2020). Key genes and pathways in tumor-educated dendritic cells by bioinformatical analysis. Microbiol. Immunol. 64, 63-71. https://doi.org/10.1111/1348-0421.12747
- Nefedova, Y., Cheng, P., Gilkes, D., Blaskovich, M., Beg, A.A., Sebti, S.M., and Gabrilovich, D.I. (2005). Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. J. Immunol. 175, 4338-4346. https://doi.org/10.4049/jimmunol.175.7.4338
- Padoan, A., Plebani, M., and Basso, D. (2019). Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity. Int. J. Mol. Sci. 20, 676. https://doi.org/10.3390/ijms20030676
- Ren, B., Cui, M., Yang, G., Wang, H., Feng, M., You, L., and Zhao, Y. (2018). Tumor microenvironment participates in metastasis of pancreatic cancer. Mol. Cancer 17, 108. https://doi.org/10.1186/s12943-018-0858-1
- Takasawa, S. (2016). Regenerating gene (REG) product and its potential clinical usage. Expert Opin. Ther. Targets 20, 541-550. https://doi.org/10.1517/14728222.2016.1123691
- Tjomsland, V., Spangeus, A., Sandstrom, P., Borch, K., Messmer, D., and Larsson, M. (2010). Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor. PLoS One 5, e13441. https://doi.org/10.1371/journal.pone.0013441
- Wang, J., Zhou, H., Han, Y., Liu, X., Wang, M., Wang, X., Yin, G., Li, X., and Xiang, M. (2014). SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. J. Mol. Med. (Berl.) 92, 1257-1269. https://doi.org/10.1007/s00109-014-1184-8
- Yamamoto, T., Yanagimoto, H., Satoi, S., Toyokawa, H., Yamao, J., Kim, S., Terakawa, N., Takahashi, K., and Kwon, A.H. (2012). Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection. J. Surg. Res. 173, 299-308. https://doi.org/10.1016/j.jss.2010.09.027
- Yan, J., Smyth, M.J., and Teng, M.W.L. (2018). Interleukin (Il)-12 and Il-23 and their conflicting roles in cancer. Cold Spring Harb. Perspect. Biol. 10, a028530. https://doi.org/10.1101/cshperspect.a028530
- Yin, G., Du, J., Cao, H., Liu, X., Xu, Q., and Xiang, M. (2015). Reg3g promotes pancreatic carcinogenesis in a murine model of chronic pancreatitis. Dig. Dis. Sci. 60, 3656-3668. https://doi.org/10.1007/s10620-015-3787-5
- Zhang, M.Y., Wang, J., and Guo, J. (2019). Role of regenerating islet-derived protein 3A in gastrointestinal cancer. Front. Oncol. 9, 1449. https://doi.org/10.3389/fonc.2019.01449